Regulation of Glioma Cells Migration by DYRK2

Gastrokine-2 suppresses epithelial mesenchymal transition through PI3K/AKT/GSK3β signaling in gastric cancer

(2016) Jin Dai et al.   TUMOR BIOLOGY

Interleukin-11 promotes epithelial-mesenchymal transition in anaplastic thyroid carcinoma cells through PI3K/Akt/GSK3β signaling pathway activation

(2016) Zhaoming Zhong et al.   Oncotarget

Soluble epoxide hydrolase inhibition ameliorates proteinuria-induced epithelial-mesenchymal transition by regulating the PI3K-Akt-GSK-3β signaling pathway

(2015) Yaoxian Liang et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

CXCR2/CXCL5 axis contributes to epithelial–mesenchymal transition of HCC cells through activating PI3K/Akt/GSK-3β/Snail signaling

(2015) Shao-Lai Zhou et al.   CANCER LETTERS

Silencing of DYRK2 increases cell proliferation but reverses CAM-DR in Non-Hodgkin's Lymphoma

(2015) Yuchan Wang et al.   INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES

DYRK2 regulates epithelial-mesenchymal-transition and chemosensitivity through Snail degradation in ovarian serous adenocarcinoma

(2015) Noriko Yamaguchi et al.   TUMOR BIOLOGY

Dual-specificity tyrosine phosphorylation-regulated kinase 2 (DYRK2) as a novel marker in T1 high-grade and T2 bladder cancer patients receiving neoadjuvant chemotherapy

(2015) Shunichiro Nomura et al.   BMC Urology

Molecular Heterogeneity in Glioblastoma: Potential Clinical Implications

(2015) Nicole Renee Parker et al.   Frontiers in Oncology

Downregulation of DYRK2 can be a predictor of recurrence in early stage breast cancer

(2014) Yasuko Enomoto et al.   TUMOR BIOLOGY

DYRK2 controls the epithelial–mesenchymal transition in breast cancer by degrading Snail

(2013) Rei Mimoto et al.   CANCER LETTERS

Intracerebellar application of P19-derived neuroprogenitor and naive stem cells to Lurcher mutant and wild type B6CBA mice

(2013) Zbyněk Houdek et al.   MEDICAL SCIENCE MONITOR

DYRK2 Negatively Regulates Cardiomyocyte Growth by Mediating Repressor Function of GSK-3β on eIF2Bε

(2013) Celine S. Weiss et al.   PLoS One

A clinical review of treatment outcomes in glioblastoma multiforme—the validation in a non-trial population of the results of a randomised Phase III clinical trial: has a more radical approach improved survival?

(2012) K Rock et al.   BRITISH JOURNAL OF RADIOLOGY

Expression of transforming growth factor-β1 (TGF-β1) and E-cadherin in glioma

(2012) Liu Yang et al.   TUMOR BIOLOGY

Mutual regulation between SIAH2 and DYRK2 controls hypoxic and genotoxic signaling pathways

(2012) Moisés Pérez et al.   Journal of Molecular Cell Biology

Correlation of the extent of tumor volume resection and patient survival in surgery of glioblastoma multiforme with high-field intraoperative MRI guidance

(2011) D. Kuhnt et al.   NEURO-ONCOLOGY

DYRK family of protein kinases: evolutionary relationships, biochemical properties, and functional roles

(2010) Sergi Aranda et al.   FASEB JOURNAL

Molecular pathology in adult gliomas: diagnostic, prognostic, and predictive markers

(2010) Michael Jansen et al.   LANCET NEUROLOGY

Application of Active and Kinase-Deficient Kinome Collection for Identification of Kinases Regulating Hedgehog Signaling

(2008) Markku Varjosalo et al.   CELL

The cell-cell adhesion molecule E-cadherin

(2008) F. van Roy et al.   CELLULAR AND MOLECULAR LIFE SCIENCES